1. Field of Invention
This invention relates to safe hypodermic needles wherein the needle is protected after injection to prevent medical practitioners from receiving needle stick injuries and infections.
2. Description of Related Art
The present invention is directed in general to a safe needle device for syringes as used in the medical industry and hospitals. The “Improvement Patent” (classified as a UTILITY PATENT, according to the USPTO) application presents two significant improvements which are based upon numerous marketability tests (see Commercial Feasibility after the Background section below) conducted over the past several years and after FDA 510(k) approval to market the invention, issued under K010477. The two improvements are:
a) reducing the bulkiness of the device as expressed by Vanderbilt University's Medical School of Nursing, Nashville, Tenn. and other potential users.
b) providing an ergonomically more convenient location and use of the retraction release.
With the advent of AIDS and other highly infectious diseases, syringes and scalpels and other sharps devices have caused numerous injuries and infections to administering medical staff. Protective devices have been introduced to the market after the U.S. legislation in 1998, but consisted of needle covers that still left part of the needle exposed after use and thereby subjecting the clinician to exposure to contaminated blood. These devices are still on the market, but are not user friendly and safe. For example, a nurse must use two hands to prepare a patient for an injection. One hand is used to clean the area to be injected with a disinfectant while the other hand is used to inject the needle into the tissue. After removing the needle from the patient, the administering nurse must press on the spot of injection and hold the syringe in the other hand. After pressing the spot is complete (to stop the flow of blood), the nurse, in prior protective devices, then uses that hand to twist a cover over the syringe or sharp. That requires two hands during which time the needle may drip blood onto the patient or the nurse where contamination is inevitable. In addition, the maneuvering to accomplish the foregoing may cause an inadvertent puncturing of the nurse's own skin, thus inviting infection. One such device is Badger U.S. Pat. No. 5,885,257, which is a very cumbersome releasable retaining device to retract the needle where it will not cause harm. In this Improvement Patent filing the above statements remain unchanged, but the ease of handling the device during administering medication by a clinician is greatly improved and so is increased safety to the patient and clinician. Two mechanically retracting safety syringes came on the market, i.e. the Integra, marketed by BD (Becton Dickenson) of Franklin, N.J., U.S. Pat. No. 5,632,733 (Shaw) and U.S. Pat. No. 7,351,224 (Shaw) and the Vanish Point, marketed by RTI (Retractable Technology, Inc.) of Houston, Tex., and U.S. Pat. No. 6,090,077 (Shaw, 7/2000). While the spring-operated needle retraction is the same in both devices (BD and RTI), they both have their compression springs located in the front end of the syringe whereas the Grabis invention has the spring located inside the plunger. In addition, the Vanish Point does not have a Luer-Lock and, thus, does not permit interchange-ability of needles prior to use. The Integra is hard to push to cause retraction which is a detriment for single hand operation because it can cause significant patient discomfort especially when the device is triggered while the needle is still in the patient. The spring assembly in the Integra (BD) can easily be removed after retraction; it falls apart. In U.S. Pat. No. 5,053,010, McGary states in claim 1. “. . . a cutting tip configured inside said sealing member . . . ” in claim 2 he states “. . . said cutting tip is a beveled knife”. The Grabis invention does not use any cutting tip. It uses a mechanically inter-locking tip-lock. In U.S. Pat. No. 5,211,629, Pressly (10/1991) states “Positioned between sacrificial supports in the needle assembly and the barrel is a deformable base and . . . the plunger has a rupturable boot”. The McGary and Pressly inventions are quite a departure from the Grabis invention. After extensive marketability testing and commercial feasibility evaluation, the Grabis invention was made faster in retraction, smaller in the outer diameter, lighter and cheaper to manufacture.
A self-retracting safety syringe has a hollow syringe body, a hollow needle having a point at its tip and a tip-lock at its base, a sleeve around the needle configured to sealingly retain the needle, a hollow plunger configured to engage the interior walls of the syringe body, the plunger having a tip sealingly engaged with the interior walls and having an aperture therein to accommodate the tip-lock, a collar circumferentially mounted on the interior wall of the plunger, a retractor for accepting and retaining the tip-lock, wherein the distal end is retained within the proximal end of the plunger by the collar, and a spring biasing the retractor against the collar, wherein the tip-lock and plunger join, and wherein the retractor is pushed past the collar and is adapted to pull the needle from within the sleeve into the hollow plunger.
In an embodiment, the sleeve has a Luer-lock connection with the proximal end of the body to sealingly retain the needle against the body.
A manually-retracting safety syringe has a hollow syringe body configured to deliver fluids to a patient, a hollow needle having a point at its tip and a tip-lock at its base, wherein the tip-lock comprises a male protrusion configured to engage with end of the plunger, a sleeve around the needle configured to sealingly retain the needle, and a plunger configured to slidingly engage the interior walls of the syringe body, the plunger having distal and proximal ends and a breaking point along its length, the plunger having a tip sealingly engaged with the interior walls of the syringe body, the tip having an aperture therein to accept and retain the tip-lock, wherein when the plunger tip pushes against the tip-lock, the tip-lock is retained by the aperture, and the plunger is adapted to pull the needle from within the sleeve into the syringe body, and wherein the plunger may be broken off at the breaking point to safely retain the needle within the syringe body.
In an embodiment the breaking point is a crease on the plunger, or indents on the plunger.
The foregoing, and other features and advantages of the invention, will be apparent from the following, more particular description of the preferred embodiments of the invention, the accompanying drawings, and the claims.
For a more complete understanding of the present invention, the objects and advantages thereof, reference is now made to the ensuing descriptions taken in connection with the accompanying drawings briefly described as follows.
Preferred embodiments of the present invention and their advantages may be understood by referring to Figs. (x-y) wherein like reference numerals refer to like elements.
It is a general object of the improvements to the original invention, as shown in patent U.S. Pat. No. 6,322,540 B1 to provide a further improved retractable safety needle device for syringes.
In accordance with the above object, there is provided a needle-stick safety syringe comprising a tubular body, cylindrical plunger, and extended needle at the distal end of the tubular body. Said needle to be removable, through attachment means, in order to be replaced with a different size needle if so desired or required based upon patient needs.
Referring now to
The coil spring 22 is positioned inside said plunger 1 behind a collar 28 on the interior of the plunger 1 that provides means to interconnect said plunger 1 with said needle base 20. A stop (not shown) inside said plunger is limiting further expansion of said spring 22 after said needle retraction is activated. Through the force of the uncoiling compression spring 22 in the plunger 1, the needle 4 is pulled out of the sleeve 7 and retracted fully into the plunger 1 (see
The tip-lock engages with the plunger and locks to the plunger tip. The spring serves to retract the needle 4 when activated by the tip-lock, which pushes the receiver through the collar after the needle's tip-lock is connected to the tip of the plunger 1 (see
With reference to
With further reference to
In use, as the plunger 60 descends, the seal 66, attached to the proximal end 62 of the plunger 60, sealingly pressurizes liquids within the cylinder 75 such that they are evacuated out the needle 52, typically into a patient. The needle 52 has a channel therein to permit the passage of fluids therethrough. The tip lock 56, extending from the distal end 64 of the needle, is mounted on supports 77 to permit fluid to flow past the tip-lock 56 into the channel The seal 66 has an aperture therein to permit access to the retractor 70. As the plunger 60 is depressed, the tip-lock 56 enters the retractor 70, and is locked therein. At the proximal end, the retractor 70 has a receiver adapted to receive and retain the tip-lock 56, and a stop to prevent the tip-lock 56 from moving through the retractor 70. As the plunger 60 is further depressed, the tip-lock 56 passes the retractor 70 opening and pushes against the stop, which force causes the distal end of the retractor 70 to push against the collar 73, and move past the collar 73 to enter the distal end of the interior of the plunger 60. As the retractor 70 is spring biased into the distal end of the plunger 60, it moves with some rapidity into the end, pulling the tip-lock 56, and consequently the needle 52, along with it into the body of the plunger 60. The seal 66 aperture is small in relation to the diameter of the plunger 60, and the retracted needle 52 is safely encased therein. The syringe may then be discarded.
With reference to
The invention has been described herein using specific embodiments for the purposes of illustration only. It will be readily apparent to one of ordinary skill in the art, however, that the principles of the invention can be embodied in other ways. Therefore, the invention should not be regarded as being limited in scope to the specific embodiments disclosed herein, but instead as being fully commensurate in scope with the following claims.
The present application is a continuation in part of U.S. Ser. No. 13/723,258 filed on Dec. 21, 2012 entitled “Safe Needle Device for Syringes” the entire disclosure of which is incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
Parent | 13723258 | Dec 2012 | US |
Child | 14853158 | US |